Ordonez Claudia
Insider CIK 1808290 · KROS Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-06-11 | 2021-06-15 | 1,000 | — | $0 | 98,211 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-06-11 | 2021-06-15 | 347 | $51.95 | $18.0K | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-06-11 | 2021-06-15 | 653 | $50.48 | $33.0K | 347 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-06-11 | 2021-06-15 | 1,000 | $0.48 | $480 | 1,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-05-11 | 2021-05-13 | 1,000 | — | $0 | 99,211 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-05-11 | 2021-05-13 | 1,000 | $0.48 | $480 | 1,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 1,000 | $50.15 | $50.1K | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-04-12 | 2021-04-14 | 1,000 | — | $0 | 100,211 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-14 | 400 | $59.09 | $23.6K | 600 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-14 | 367 | $60.01 | $22.0K | 233 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-14 | 233 | $61.23 | $14.3K | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-04-12 | 2021-04-14 | 1,000 | $0.48 | $480 | 1,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-03-11 | 2021-03-15 | 1,000 | — | $0 | 101,211 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-03-11 | 2021-03-15 | 395 | $64.09 | $25.3K | 605 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-03-11 | 2021-03-15 | 1,000 | $0.48 | $480 | 1,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-03-11 | 2021-03-15 | 605 | $64.86 | $39.2K | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-02-11 | 2021-02-16 | 1,000 | — | $0 | 102,211 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 2 | $68.05 | $136 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 312 | $64.17 | $20.0K | 513 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-02-11 | 2021-02-16 | 1,000 | $0.48 | $480 | 1,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 175 | $63.10 | $11.0K | 825 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 295 | $66.19 | $19.5K | 2 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 216 | $65.35 | $14.1K | 297 | SEC↗ |
| KROS | A Award deriv | 2021-01-10 | 2021-01-12 | 42,250 | — | $0 | 42,250 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2020-04-07 | 2020-04-08 | 18,430 | — | $0 | 18,430 | SEC↗ |